top of page

Knowledge Center

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Patient Stories

Personalizing Metastatic Breast Cancer Treatment Through Liquid Biopsy | Dr. Shane Dormady

Patient Stories

2026年5月20日

Personalizing Metastatic Breast Cancer Treatment Through Liquid Biopsy | Dr. Shane Dormady

Read More
Personalizing Metastatic Breast Cancer Treatment Through Liquid Biopsy | Dr. Shane Dormady
透過液體活檢推動精準癌症治療方案的選擇｜Gilberto Lopes醫師

Patient Stories

2025年12月19日

透過液體活檢推動精準癌症治療方案的選擇｜Gilberto Lopes醫師

Read More
透過液體活檢推動精準癌症治療方案的選擇｜Gilberto Lopes醫師

Publications

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Publications

2025年12月1日

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Read More
Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Publications

2025年11月13日

High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Read More
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Publications

2025年11月12日

Predictive Model for Mortality Risk
Stratification Using Laboratory
Biomarkers in Singaporeans

Read More
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Insights

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Article

2026年5月26日

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Read More
Add
Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Article

2026年5月26日

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Read More
Add
Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Article

2026年5月26日

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Read More
Add

Clinical Insights

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Article

2026年5月26日

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Read More
Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid
Why “Early Detection” Is Not the Same as “Screening”

Article

2026年5月19日

Why “Early Detection” Is Not the Same as “Screening”

Read More
Why “Early Detection” Is Not the Same as “Screening”

News & Updates

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

News & Updates

2026年3月18日

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

Read More
Add
Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research

News & Updates

2026年3月13日

Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research

Read More
Add
Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia

News & Updates

2026年3月5日

Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia

Read More
Add

Webinars

Mayo Clinic Laboratories: The next generation of liquid biopsy testing

Webinars

2025年11月12日

Mayo Clinic Laboratories: The next generation of liquid biopsy testing

Visit
Mayo Clinic Laboratories: The next generation of liquid biopsy testing
New Frontiers in Liquid Biopsy for Lung Cancer

Webinars

2021年6月30日

New Frontiers in Liquid Biopsy for Lung Cancer

Read More
New Frontiers in Liquid Biopsy for Lung Cancer

Case Studies

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Case Studies

2025年11月12日

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Read More
LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer
bottom of page